Reshma Kewalramani stock trades
CEO & President of Vertex Pharmaceuticals
1 open-market trade reported in the last 12 months: 1 sale for $19.7M. One sale was under a trading plan set up in advance. The newest was filed Mar 3.
Where Reshma Kewalramani files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 1 |
Reshma Kewalramani's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site. A Plan tag marks a sale under a trading plan set up in advance.
| Stock | Trade | Traded |
|---|---|---|
| SellPlan$19.7M | Feb 27SEC filing |
6 other filings on record (tax withholdings and stock awards). Pro members see every trade, the shares Reshma Kewalramani held after each, and every filing.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at Vertex Pharmaceuticals
- Jeffrey M. Leiden
- Carmen Bozic
- Ourania Tatsis
- Jonathan Biller
- Edward Morrow Atkinson III
- Joy Liu
- Kristen Ambrose
- Mark E. Bunnage
- Duncan McKechnie
- Amit Sachdev
- Charles F. Wagner Jr.
- David Altshuler
- Jasper van Grunsven
- Sangeeta N. Bhatia
- Lloyd Carney
- Alan M. Garber
- Bruce I. Sachs
- Diana McKenzie
- Jennifer Schneider
- Nancy Thornberry
- Suketu Upadhyay